Endosialin/CD248 may be a potential therapeutic target to prevent the invasion and metastasis in osteosarcoma.

• Material Type: 博士論文
• Title: Endosialin/CD248 may be a potential therapeutic target to prevent the invasion and metastasis in osteosarcoma.
• Author/Editor: Kondo, Yumiko; Honoki, Kanya; Kishi, Shingo; Mori, Shiori; Fujiwara-Tani, Rina; Tsukamoto, Shinji; Fujii, Hiromasa; Kuniyasu, Hiroki; Tanaka, Yasuhito
• Author Heading: Kondo, Yumiko; Honoki, Kanya; Kishi, Shingo; Mori, Shiori; Fujiwara-Tani, Rina; Tsukamoto, Shinji; Fujii, Hiromasa; Kuniyasu, Hiroki; Tanaka, Yasuhito
• Publication, Distribution, etc.: Spandidos Publications
• Publication Date: 2022-02
• Publication Date (W3CDTF): 2022-02
• Alternative Title: エンドシアリン/CD248は骨肉腫の浸潤と転移を抑制する潜在的な治療標的となる可能性がある
• Periodical title: Oncology letters
• No. or year of volume/issue: 23 2
• Volume: 23
• Issue: 2
• Pages: Article No.42-
• ISSN (Periodical Title): ISSN : 1792-1074
• Degree grantor/type: 奈良県立医科大学
• Date Granted: 2022-03-15
• Dissertation Number: 甲第829号
• Degree Type: 博士（医学）
• Text Language Code: eng
• Subject Heading: osteosarcoma; endosialin; invasion; metastasis
• Target Audience: 一般
• Note (General): type:Thesis; Endosialin/CD248/tumor endothelial marker 1 is classified as a C-type lectin-like transmembrane receptor, found on the plasma membrane of activated mesenchymal cells, which binds to fibronectin. Although endosialin is expressed at high levels in stem-like cells of sarcomas, its role has not been fully uncovered. The present study aimed to determine whether endosialin expression is associated with tumor progression and metastasis, and whether endosialin has the potential to act as a novel therapeutic target in osteosarcoma (OS) using MORAb-004/ontuxizumab, a humanized monoclonal antibody, which targets the type C lectin domain of endosialin. The results demonstrated that endosialin was highly expressed in OSs with metastatic disease. Furthermore, MORAb-004 had no cytostatic effect on OS cells in vitro and did not change the expression of stem cells and differentiation markers; however, it inhibited migration of OS cells. Taken together, these results suggest that endosialin may play a role in migration, and may be involved in the metastatic process of OSs. Furthermore, MORAb-004 reduces the motility of OS cells, and suppresses invasion and the development of metastatic lesions.; 博士（医学）・甲第829号・令和4年3月15日; Copyright: © Kondo et al. This is an open access article distributed under the terms of Creative Commons Attribution License(https://creativecommons.org/licenses/by-nc-nd/4.0/).; identifier:Oncology letters Vol.23 No.2 Article No.42 (2022 Feb); identifier:17921074; identifier:http://ginmu.naramed-u.ac.jp/dspace/handle/10564/4012; identifier:Oncology letters, 23(2): Article No.42
• Access Restrictions: インターネット公開
• Related Material (DOI): 10.3892/ol.2021.13160
• Data Provider (Database): 国立情報学研究所 : 学術機関リポジトリデータベース（IRDB）（機関リポジトリ）; https://irdb.nii.ac.jp
• Original Data Provider (Database): 奈良県立医科大学 : 奈良県立医科大学機関リポジトリ GINMU

Table of Contents

http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/4012/1/01%e7%94%b2829%e6%9c%ac%e6%96%87%e3%81%ae%e8%a6%81%e6%97%a8.pdf fulltext

http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/4012/2/02%e7%94%b2829%e5%af%a9%e6%9f%bb%e8%a6%81%e6%97%a8.pdf fulltext

http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/4012/3/03%e7%94%b2829%e6%9c%ac%e6%96%87.pdf fulltext